• info@glspharma.com
    Follow Us:
logo
  • Home
  • About Us
    • Our Purpose
    • Board of Directors
    • Director's Message
  • Oncology Products
    • Solid Malignancies
      • Injectable
      • Oral Solid Dosage Forms
    • Supportive Care Therapy
      • Supportive Care Products
    • Haematologicals
      • Haematological Products
  • Facilities
    • Manufacturing
    • Collaboration
    • Distribution
  • Clientele
    • Domestic
    • International
  • Certifications
  • Updates
  • Blogs
  • Contact Us

Injectable

no text

PEGLIDOX

  • no text

    5 FU-GLS

  • no text

    CARBOMAX

  • no text

    CARNUMAX

  • no text

    CISMAX

  • no text

    CTX-GLS

  • no text

    DOCEMAX

  • no text

    DOXOGET

  • no text

    EPIGET

  • no text

    ETOVEL

  • no text

    FASLOMAX

  • no text

    GEMGET

  • no text

    GIOPEM

  • no text

    IPOGET

  • no text

    METHOGET

  • no text

    OXALIMAX

  • no text

    PACGET

  • no text

    PROLEMAX

  • no text

    VINBLASTINE GLS 10

  • no text

    VINCRISTINE GLS 1

  • no text

    MESNA

  • ×
    ❮ ❯

    • 011-45586751
    • info@glspharma.com
    • Corporate Office: F-30, Phase-1, Okhla Industrial Estate, New Delhi - 110020, INDIA Delhi, India 110017
    • Manufacturing Unit: Plot No-10, IDA, Phase-I Jeedimetla, Hyderabad, 500055, (India)

    Quick Link

    • Home
    • About Us
    • Certifications
    • Facilities

    • Clientele
    • Updates
    • Blogs
    • Contact Us

    Copyright © 2019 GLS Pharma Pvt. Ltd. All rights reserved.
    • Contact Us
    • About Us
    • Home
    • Blog